U.S. will ease travel restrictions for vaccinated foreign visitors
Yahoo Finance's Anjalee Khemlani joins the Yahoo Finance Live panel to discuss the latest vaccine news.
Video Transcript
AKIKO: I want to turn our attention here to some stocks that, relatively on a day where we have seen a huge sell-off, are doing pretty well here. And that's, of course, the travel stocks. Some of the airline names here. You see Delta, United, and JetBlue American all up here on the back of some announcements coming out of Washington on those restrictions, the travel restrictions in place that have been in place during the pandemic being lifted. Let's bring in Yahoo Finance's Anjalee Khemlani, who's tracking that for us this morning. Anjalee.
- That's right, Akiko, so we got word from the White House COVID-19 response team this morning that they are, in fact, looking to lift the restrictions on travel. But in return, place some limitations or rather requirements on who can do what. And that is basically ensuring or requiring, rather, that any inbound international travelers from outside into the US have the following.
A, they are vaccinated and have proof of vaccination prior to boarding. If they are unvaccinated, then they will have to undergo some rigorous testing, required to test at least a day before getting on board, as well as in the post-arrival interval. Specifics on exactly how long after or how much follow up will be required remains to be hashed out.
In addition, the CDC is going to be in touch with the airlines and start requiring collection of information for contact tracing purposes, and that includes phone numbers and email addresses. This is all set to go into effect in early November, which is around the time, honestly, that some health experts have said could be the start of another wave. So the timing of it is all very interesting. There are some travel experts who have told me that they would like it to go into effect earlier, and as soon as possible. But it seems like this is all needed in order to roll out. The details of that contact tracing information is also yet to be ironed out.
Meanwhile, Pfizer got some news there, this morning. Good news for all those with kids. 5 to 11-year-olds are proving to have a positive response to the vaccine doses. Two doses, 21 days apart similar to adults.
But different in this clinical trial data is that the kids were given a 10 microgram dose, rather than the 30, which is what adults are receiving so that is just the first announcement from the company. We'll get more details later. But as it stands right now, they're looking to a follow the FDA for an emergency use authorization sometime soon, possibly getting the first shots in arms, quite honestly, by the end of October at earliest. So if all goes smoothly, that's where things stand now with that.
AKIKO: A busy day for you today, Anjalee. Appreciate the update.
